Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microtubule plus-end binding protein Bim1 (Bim1p) in budding yeast (*S. cerevisiae*) belongs to the EB family of proteins that regulate microtubule dynamics by associating with growing microtubule plus ends. It plays essential roles during mitosis, including spindle positioning, chromosome segregation, and coordination of spindle elongation through interactions with other proteins such as Kar9p and Bik1p[9][5][8]. Phosphorylation by Aurora kinase Ipl1 modulates its activity during anaphase[5]. Loss of Bim1 function leads to severe defects in mitotic progression and cell viability due to impaired organization of the microtubule cytoskeleton[8]. "Bim1p is a microtubule plus-end binding protein involved in microtubule depolymerization, nucleation, mitotic sister chromatid cohesion and mitotic spindle positioning" [9]. "The budding yeast EB1 homologue Bim1p...is regulated by Aurora B/Ipl1-mediated multisite phosphorylation...required for normal spindle elongation kinetics" [5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microtubule plus-end binding protein Bim1 (Bim1p).